Sublingual piroxicam in migraine without aura

Journal of Association of Physicians of India

Volumn 59, Issue 8, 2011, Pages 494-497

  Ravishankar, K ^a   Tayade, Himanshu ^b   Mandlik, Rahul ^b  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^b Meyer Organics Pvt Ltd Wagle Estate   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; PAIN; PAIN MEASUREMENT; PIROXICAM; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053327898     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mueller LL. Diagnosing and managing migraine headache. J Am Osteopath Assoc 2007;107(10 Suppl 6): ES10-ES16.
2. Brogden RN, Heel RC, Speight TM, Avery GS. Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy. Drugs 1984;28:292-323.
3. Ando GA, Lombardino JG. Piroxicam--a literature review of new results from laboratory and clinical studies. Eur J Rheumatol Inflamm 1983;6:3-23.
4. Nappi G, Micieli G, Tassorelli C, Viotti E, Altavilla T. Effectiveness of a piroxicam fast dissolving formulation sublingually administered in the symptomatic treatment of migraine without aura. Headache 1993;33:296-300.
5. S upervía A, Pedro-Botet J, Nogués X, Echarte JL, Mínguez S, Iglesias ML, Gelabert A. Piroxicam fast-dissolving dosage form vs diclofenac sodium in the treatment of acute renal colic: a doubleblind controlled trial. Br J Urol 1998;81:27-30.
6. S elçuk E, Gomel M, Apaydin S, Köse T, Tuglular I. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium. Int J Clin Pharmacol Res 1998;18:21-9.
7. Alpaslan C, Alpaslan G, Uǧar D. Postoperative pain control by single doses of piroxicam administered sublingually and aspirin. J Marmara Univ Dent Fac 1997;2:658-64.
8. Minisola G, Bancheri C, Bogliolo A, Brundisini B, Gospodinoff L, Lucentini L, Porzio F, Perpignano G. Clinical experience with the use of piroxicam in fast-dissolving sublingual capsules in acute recurrent osteoarthritis. Clin Ter 1993;143:519-29.
9. Consoli G, Covelli M, Di Matteo L, Marcolongo R, Tirri G, La Montagna G, Pipitone V. Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis: Multicenter clinical trial. Minerva Med 1994;85:89-96.
10. Englert R, Fontanesi G, Müller P, Ott H, Rehn L, Silva H. Piroxicam fast-dissolving dosage form in the treatment of patients with acute low back pain. Clin Ther 1996;18:843-52.
11. Ragni N, Ciccarelli A. Primary dysmenorrhea treated with sublingual piroxicam. Minerva Ginecol. 1993;45:365-75.